덱스컴(주)
DE ˙ DB ˙ US2521311074
€62.20 ↓ -0.20 (-0.32%)
2026-06-04
주가
SecurityDE:DC4 / DexCom, Inc.
InstitutionBellevue Group AG
Latest Disclosed Ownership788,766 shares
Latest Disclosed Value $ 49,534,505
Bellevue Group AG reports 6.92% decrease in ownership of DC4 / DexCom, Inc.

On May 14, 2026 - Bellevue Group AG filed a 13F-HR form disclosing ownership of 788,766 shares of DexCom, Inc. (DE:DC4) valued at $42,743,230 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 847,405 shares of DexCom, Inc.. This represents a change in shares of -6.92% during the quarter. The current value of the position is $49,061,245 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F DEXCOM COM 252131107 788,766 -58,639 -6.92 49,535 -11.93 1.1708
2026-02-17 2025-12-31 13F DEXCOM COM 252131107 847,405 61,287 7.80 56,242 6.32 1.0658
2025-11-14 2025-09-30 13F DEXCOM COM 252131107 786,118 -74,710 -8.68 52,898 -29.60 1.0991
2025-08-14 2025-06-30 13F DEXCOM COM 252131107 860,828 -203,280 -19.10 75,142 3.40 1.6561
2025-05-14 2025-03-31 13F DEXCOM COM 252131107 1,064,108 19,064 1.82 72,668 -10.59 1.6283
2025-02-14 2024-12-31 13F DEXCOM COM 252131107 1,045,044 28,006 2.75 81,273 19.20 1.5644
2024-11-14 2024-09-30 13F DEXCOM COM 252131107 1,017,038 -251,649 -19.84 68,182 -52.60 1.1046
2024-08-14 2024-06-30 13F DEXCOM COM 252131107 1,268,687 47,490 3.89 143,844 -15.08 2.3373
2024-05-15 2024-03-31 13F DEXCOM COM 252131107 1,221,197 306,604 33.52 169,380 49.25 2.5832
2024-02-14 2023-12-31 13F DEXCOM COM 252131107 914,593 228,860 33.37 113,492 77.39 1.7360
2023-11-14 2023-09-30 13F DEXCOM COM 252131107 685,733 -75,983 -9.98 63,979 -34.64 1.0308
2023-08-14 2023-06-30 13F DEXCOM COM 252131107 761,716 6,637 0.88 97,888 11.59 1.3963
2023-05-15 2023-03-31 13F DEXCOM COM 252131107 755,079 -233,397 -23.61 87,725 -21.63 1.2730
2023-02-14 2022-12-31 13F DEXCOM COM 252131107 988,476 128,016 14.88 111,935 61.52 1.4856
2022-11-14 2022-09-30 13F DEXCOM COM 252131107 860,460 -68,048 -7.33 69,301 0.14 0.9946
2022-08-11 2022-06-30 13F DEXCOM COM 252131107 928,508 693,608 295.28 69,202 -42.42 0.9782
2022-05-13 2022-03-31 13F DEXCOM COM 252131107 234,900 -253 -0.11 120,175 -4.82 1.3954
2022-02-10 2021-12-31 13F DEXCOM COM 252131107 235,153 -28,686 -10.87 126,265 -12.49 1.3015
2021-11-12 2021-09-30 13F DEXCOM COM 252131107 263,839 19,063 7.79 144,283 38.04 1.4642
2021-08-12 2021-06-30 13F DEXCOM COM 252131107 244,776 28,583 13.22 104,519 34.52 1.0203
2021-05-12 2021-03-31 13F DEXCOM COM 252131107 216,193 2,886 1.35 77,698 -1.48 0.8221
2021-02-16 2020-12-31 13F DEXCOM COM 252131107 213,307 91,602 75.27 78,864 57.19 0.9032
2020-11-16 2020-09-30 13F DEXCOM COM 252131107 121,705 19,000 18.50 50,170 20.49 0.6932
2020-08-13 2020-06-30 13F DEXCOM COM 252131107 102,705 1,377 1.36 41,637 52.60 0.5893
2020-05-14 2020-03-31 13F DEXCOM COM 252131107 101,328 22,853 29.12 27,285 58.95 0.5291
2020-02-14 2019-12-31 13F DEXCOM COM 252131107 78,475 -90,412 -53.53 17,166 -31.89 0.2722
2019-11-14 2019-09-30 13F DEXCOM COM 252131107 168,887 3,751 2.27 25,205 1.86 0.4688
2019-08-14 2019-06-30 13F DEXCOM COM 252131107 165,136 33,990 25.92 24,744 58.42 0.4225
2019-05-15 2019-03-31 13F DEXCOM COM 252131107 131,146 53,338 68.55 15,619 67.57 0.8594
2019-02-12 2018-12-31 13F DEXCOM COM 252131107 77,808 6,161 8.60 9,321 -9.05 0.6128
2018-11-13 2018-09-30 13F DEXCOM COM 252131107 71,647 -199,250 -73.55 10,248 -60.17 0.6501
2018-08-07 2018-06-30 13F DEXCOM COM 252131107 270,897 -85,493 -23.99 25,730 -2.65 2.1935
2018-05-09 2018-03-31 13F DEXCOM COM 252131107 356,390 89,650 33.61 26,430 72.68 2.6184
2018-02-14 2017-12-31 13F DEXCOM COM 252131107 266,740 221,740 492.76 15,306 595.10 1.5990
2017-11-13 2017-09-30 13F DEXCOM COM 252131107 45,000 7,500 20.00 2,202 -19.72 0.2303
2017-08-14 2017-06-30 13F DEXCOM COM 252131107 37,500 1,400 3.88 2,743 -10.33 0.3243
2017-05-11 2017-03-31 13F DEXCOM COM 252131107 36,100 -4,900 -11.95 3,059 24.96 0.4076
2017-02-10 2016-12-31 13F DEXCOM COM 252131107 41,000 41,000 13.57 2,448 -19.97 0.5013
2016-08-12 2016-06-30 13F DexCom COM 252131107 0 -20,000 -100.00 0 -100.00
2016-05-16 2016-03-31 13F DexCom COM 252131107 20,000 20,000 1,358 0.2464
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.